Finally,an EEG forward model based onapre-estimated lead field matrix wasconstructed together with the ROIsource model togenerate scalp EEG observations.

Assuming that small spatial structures are more-or-less consistent across these measurements, these methods project to a local low-rank approximation of the data [37,31].

Magnetic Resonance Imaging (MRI) is a powerful medical imaging modality that offers diagnostic information without harmful ionizing radiation.

Magnetic Resonance Imaging (MRI) is a powerful medical imaging modality that offers diagnostic information without harmful ionizing radiation.

Functional magnetic resonance imaging (fMRI) analysis faces significant challenges due to limited dataset sizes and domain variability between studies. Traditional self-supervised learning methods inspired by computer vision often rely on positive and negative sample pairs, which can be problematic for neuroimaging data where defining appropriate contrasts is non-trivial. We propose adapting a recently developed Hierarchical Functional Maximal Correlation Algorithm (HFMCA) to graph-structured fMRI data, providing a theoretically grounded approach that measures statistical dependence via density ratio decomposition in a reproducing kernel Hilbert space (RKHS),and applies HFMCA-based pretraining to learn robust and generalizable representations. Evaluations across five neuroimaging datasets demonstrate that our adapted method produces competitive embeddings for various classification tasks and enables effective knowledge transfer to unseen datasets. Codebase and supplementary material can be found here: https://github.com/fr30/mri-eigenencoder

The widespread use of Magnetic Resonance Imaging (MRI) in combination with deep learning shows promise for many high-impact automated diagnostic and prognostic tools. However, training new models requires large amounts of labeled data, a challenge due to high cost of precise annotations and data privacy. To address this issue, we introduce the MRI-CORE, a vision foundation model trained using more than 6 million slices from over 110 thousand MRI volumes across 18 body locations. Our experiments show notable improvements in performance over state-of-the-art methods in 13 data-restricted segmentation tasks, as well as in image classification, and zero-shot segmentation, showing the strong potential of MRI-CORE to enable data-efficient development of artificial intelligence models. We also present data on which strategies yield most useful foundation models and a novel analysis relating similarity between pre-training and downstream task data with transfer learning performance. Our model is publicly available with a permissive license. Magnetic Resonance Imaging (MRI) is one of the most widely used imaging modalities in medical diagnostics, with around 100-150 million scans performed annually worldwide (Papanicolas et al. 2018). MRI supports a wide range of clinical tasks, including lesion detection, tissue classification, and disease monitoring. Among these tasks, segmentation plays a particularly important role, as it enables precise delineation of anatomical structures and pathological regions, directly impacting diagnosis, treatment planning, and longitudinal studies (Mazurowski et al. 2023; Ma et al. 2024; Azad et al. 2024; Xu et al. 2024). Recent advances in deep learning have significantly improved the automation and accuracy of MRI-based analyses across a variety of tasks. However, deep learning-based methods typically require large amounts of manually annotated data and lack task transferability, making them difficult to scale across new tasks, anatomies, or patient populations.

The accurate segmentation of myocardial scars from cardiac MRI is essential for clinical assessment and treatment planning. In this study, we propose a robust deep-learning pipeline for fully automated myocardial scar detection and segmentation by fine-tuning state-of-the-art models. The method explicitly addresses challenges of label noise from semi-automatic annotations, data heterogeneity, and class imbalance through the use of Kullback-Leibler loss and extensive data augmentation. We evaluate the model's performance on both acute and chronic cases and demonstrate its ability to produce accurate and smooth segmentations despite noisy labels. In particular, our approach outperforms state-of-the-art models like nnU-Net and shows strong generalizability in an out-of-distribution test set, highlighting its robustness across various imaging conditions and clinical tasks. These results establish a reliable foundation for automated myocardial scar quantification and support the broader clinical adoption of deep learning in cardiac imaging.

A common neurodegenerative disease, Alzheimer's disease requires a precise diagnosis and efficient treatment, particularly in light of escalating healthcare expenses and the expanding use of artificial intelligence in medical diagnostics. Many recent studies shows that the combination of brain Magnetic Resonance Imaging (MRI) and deep neural networks have achieved promising results for diagnosing AD. Using deep convolutional neural networks, this paper introduces a novel deep learning architecture that incorporates multiresidual blocks, specialized spatial attention blocks, grouped query attention, and multi-head attention. The study assessed the model's performance on four publicly accessible datasets and concentrated on identifying binary and multiclass issues across various categories. This paper also takes into account of the explainability of AD's progression and compared with state-of-the-art methods namely Gradient Class Activation Mapping (GradCAM), Score-CAM, Faster Score-CAM, and XGRADCAM. Our methodology consistently outperforms current approaches, achieving 99.66\% accuracy in 4-class classification, 99.63\% in 3-class classification, and 100\% in binary classification using Kaggle datasets. For Open Access Series of Imaging Studies (OASIS) datasets the accuracies are 99.92\%, 99.90\%, and 99.95\% respectively. The Alzheimer's Disease Neuroimaging Initiative-1 (ADNI-1) dataset was used for experiments in three planes (axial, sagittal, and coronal) and a combination of all planes. The study achieved accuracies of 99.08\% for axis, 99.85\% for sagittal, 99.5\% for coronal, and 99.17\% for all axis, and 97.79\% and 8.60\% respectively for ADNI-2. The network's ability to retrieve important information from MRI images is demonstrated by its excellent accuracy in categorizing AD stages.

Alzheimer's disease is an untreatable, progressive brain disorder that slowly robs people of their memory, thinking abilities, and ultimately their capacity to complete even the most basic tasks. Among older adults, it is the most frequent cause of dementia. Although there is presently no treatment for Alzheimer's disease, scientific trials are ongoing to discover drugs to combat the condition. Treatments to slow the signs of dementia are also available. Many researchers throughout the world became interested in developing computer-aided diagnosis systems to aid in the early identification of this deadly disease and assure an accurate diagnosis. In particular, image based approaches have been coupled with machine learning techniques to address the challenges of Alzheimer's disease detection. This study proposes a computer aided diagnosis system to detect Alzheimer's disease from biomarkers captured using neuroimaging techniques. The proposed approach relies on deep learning techniques to extract the relevant visual features from the image collection to accurately predict the Alzheimer's class value. In the experiments, standard datasets and pre-trained deep learning models were investigated. Moreover, standard performance measures were used to assess the models' performances. The obtained results proved that VGG16-based models outperform the state of the art performance.

Magnetic Resonance Imaging (MRI) is an essential tool for the early detection, risk stratification, prognosis, treatment selection, and monitoring of many diseases, including cancer, cardiovascular disease, metabolic, musculoskeletal, and brain disorders, among many others. Its ability to produce multi-contrast and multi-parametric images of soft tissues, coupled with its non-invasive and radiation-free nature, makes it a highly valuable tool in clinical practice. Over the past five decades, the technology behind MRI has undergone significant advancements, especially in terms of the magnetic field strengths used for imaging. Early MRI systems operated at low field strengths (0.15 T to 0.35 T) [1-3], and while they offered important diagnostic insights, they were limited by low signal-to-noise ratio (SNR) and image resolution. Over time, several advancements led to the development of systems operating at higher field strengths, such as 1.5 T and 3 T, which are now considered the clinical standard due to their superior SNR and image quality [4, 5]. Recent developments have even pushed field strengths to ultra-high levels ( 3 T), including 5 T, 7 T and beyond, further enhancing the spatial and temporal resolution of MRI [4, 6, 7]. However, high-field MRI has its challenges [8].